triazoles has been researched along with Viremia in 9 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 9 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Caskey, M; Evering, TH; Garmon, D; La Mar, M; Markowitz, M; Mohri, H; Palmer, S; Prada, N; Rodriguez, K; Sahi, V | 1 |
Beliakova-Bethell, N; Dubé, MP; Goicoechea, M; Haubrich, R; Jain, S; Lada, SM; Rought, SE; Spina, CA; Sun, X; Witt, MD; Woelk, CH | 1 |
Caballero, E; Cabezas, T; De Mendoza, C; Eiros, JM; Lopez, M; Parra, P; Poveda, E; Roc, L; Rodríguez, C; Soriano, V; Treviño, A | 1 |
Assoumou, L; Autran, B; Campillo-Gimenez, L; Capeau, J; Costagliola, D; Guihot, A; Katlama, C; Marcelin, AG; Pajanirassa, P; Soulié, C; Valantin, MA; Villemonteix, J | 1 |
Chung, HK; Galmin, L; Pal, R; Rose, N; Suschak, J | 1 |
D'Avolio, A; Fuchs, D; Gisslén, M; Hagberg, L; Svennerholm, B; Verhofstede, C; Watson, V; Yilmaz, A | 1 |
Abad, M; Casado, JL; Dahl, V; Díaz, L; Dronda, F; Gutiérrez, C; Hernández-Novoa, B; Madrid, N; Moreno, AM; Moreno, S; Muñoz, E; Muñoz-Fernández, MÁ; Navas, E; Palmer, S; Pérez-Elías, MJ; Rubio, R; Vallejo, A; Zamora, J | 1 |
Acosta, EP; Barreca, ML; Chirullo, B; Collins, M; Della Corte, A; Greenhouse, J; Iraci, N; Lewis, MG; Norelli, S; Savarino, A; Shytaj, IL; Yalley-Ogunro, J | 1 |
Baraki, B; Benko, E; Brumme, ZL; Danroth, R; Huibner, S; Kaul, R; Kovacs, C; Le, AQ; Mazzulli, T; Osborne, BJ; Porte, Cl; Sheth, PM; Yi, TJ | 1 |
3 trial(s) available for triazoles and Viremia
Article | Year |
---|---|
A randomized open-label study of 3- versus 5-drug combination antiretroviral therapy in newly HIV-1-infected individuals.
Topics: Adult; Aged; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; CD4 Lymphocyte Count; Cyclohexanes; DNA, Viral; Drug Combinations; Endpoint Determination; HIV Infections; Humans; Longitudinal Studies; Male; Maraviroc; Middle Aged; Pyrrolidinones; Raltegravir Potassium; RNA, Viral; Triazoles; Viral Load; Viremia | 2014 |
Treatment intensification has no effect on the HIV-1 central nervous system infection in patients on suppressive antiretroviral therapy.
Topics: Adult; Albumins; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; CD4 Lymphocyte Count; CD4-Positive T-Lymphocytes; Central Nervous System Infections; Cross-Over Studies; Cyclohexanes; Enfuvirtide; Female; HIV Envelope Protein gp41; HIV Infections; HIV-1; Humans; Immunoglobulin G; Lopinavir; Male; Maraviroc; Middle Aged; Neopterin; Peptide Fragments; Polymerase Chain Reaction; Ritonavir; RNA, Viral; Triazoles; Viral Load; Viremia; Virus Replication | 2010 |
Intensification of antiretroviral therapy with a CCR5 antagonist in patients with chronic HIV-1 infection: effect on T cells latently infected.
Topics: Adult; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Bacteria; CCR5 Receptor Antagonists; CD8-Positive T-Lymphocytes; Chronic Disease; Cyclohexanes; Disease Reservoirs; DNA, Circular; Female; HIV Infections; HIV-1; Humans; Immunologic Memory; Lymphocyte Activation; Male; Maraviroc; Middle Aged; Plasmids; Receptors, CCR5; T-Lymphocyte Subsets; T-Lymphocytes; Triazoles; Viremia | 2011 |
6 other study(ies) available for triazoles and Viremia
Article | Year |
---|---|
Maraviroc intensification in patients with suppressed HIV viremia has limited effects on CD4+ T cell recovery and gene expression.
Topics: Adult; Aged; Anti-HIV Agents; CD4 Lymphocyte Count; CD4-Positive T-Lymphocytes; Cell Proliferation; Cyclohexanes; Female; Gene Expression; Gene Expression Profiling; HIV Infections; Humans; Male; Maraviroc; Microarray Analysis; Middle Aged; Treatment Outcome; Triazoles; Tumor Necrosis Factor-alpha; Viremia | 2014 |
HIV-2 viral tropism influences CD4+ T cell count regardless of viral load.
Topics: Adult; Anti-HIV Agents; CCR5 Receptor Antagonists; CD4 Lymphocyte Count; CD4-Positive T-Lymphocytes; Cyclohexanes; Female; HIV Envelope Protein gp120; HIV Fusion Inhibitors; HIV Infections; HIV-2; Humans; Male; Maraviroc; Middle Aged; Peptide Fragments; RNA, Viral; Spain; Triazoles; Viral Load; Viral Tropism; Viremia | 2014 |
Switch to maraviroc/raltegravir dual therapy leads to an unfavorable immune profile with low-level HIV viremia.
Topics: Anti-HIV Agents; CD4-CD8 Ratio; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Cyclohexanes; Female; HIV Infections; Humans; Lymphocyte Activation; Male; Maraviroc; Middle Aged; Monocytes; Raltegravir Potassium; RNA, Viral; Treatment Outcome; Triazoles; Viral Load; Viremia | 2015 |
Characterization of a SHIV162P3 variant evolved in an infected rhesus macaque with persistent plasma viremia.
Topics: Amino Acid Substitution; Animals; Anti-HIV Agents; Antibodies, Neutralizing; CD4 Lymphocyte Count; Cyclohexanes; Gene Products, env; HIV Antibodies; Macaca mulatta; Male; Maraviroc; Mutation, Missense; Plasma; Sequence Analysis, DNA; Simian Acquired Immunodeficiency Syndrome; Simian Immunodeficiency Virus; Triazoles; Viremia | 2010 |
A highly intensified ART regimen induces long-term viral suppression and restriction of the viral reservoir in a simian AIDS model.
Topics: Adenine; Animals; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Cyclohexanes; Darunavir; Deoxycytidine; Drug Therapy, Combination; Emtricitabine; Flow Cytometry; Fluorescent Antibody Technique; Macaca mulatta; Maraviroc; Organophosphonates; Pyrrolidinones; Raltegravir Potassium; Ritonavir; Simian Acquired Immunodeficiency Syndrome; Sulfonamides; T-Lymphocyte Subsets; Tenofovir; Triazoles; Viral Load; Viremia | 2012 |
Impact of antiretroviral therapy duration and intensification on isolated shedding of HIV-1 RNA in semen.
Topics: Amino Acid Sequence; Anti-Retroviral Agents; Base Sequence; Case-Control Studies; Cyclohexanes; HIV Infections; HIV-1; Humans; Incidence; Male; Maraviroc; Molecular Sequence Data; Prospective Studies; Pyrrolidinones; Raltegravir Potassium; RNA, Viral; Semen; Sequence Analysis, RNA; Sexual Behavior; Time Factors; Treatment Outcome; Triazoles; Viral Load; Viremia; Virus Shedding | 2013 |